Gene · 55740
Papers2,448
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,448
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Immunogenicity, Reactogenicity, and Safety of a Pentavalent Meningococcal ABCWY Vaccine in Adolescents and Young Adults Who Had Previously Received a Meningococcal ACWY Vaccine: A Phase 3, Randomized Controlled Clinical Study. | Clin Infect Dis | 2025 | 39722560 | PubTator, text mining | PubMed |
| Impact on meningococcal disease of different vaccination strategies with 4CMenB and MenACWY-CRM197 in infants and adolescents in Argentina. | Vaccine | 2025 | 39719770 | PubTator, text mining | PubMed |
Randomized trial showing persistence of hSBA titers elicited by a pentavalent meningococcal MenABCWY vaccine for up to 4 years following a primary series and safety and immunogenicity of a booster dose. | Vaccine | 2025 | 39520893 | PubTator, text mining | PubMed |
| Transcriptomic analysis of circulating extracellular vesicles during the perioperative period of Fontan and Glenn surgery. | NPJ Cardiovasc Health | 2024 | 41775898 | PubTator, text mining | PubMed |
| The Role of the Cytoskeletal Regulatory Protein, Mammalian Enabling Protein (Mena), in Invasion and Metastasis of HPV16-Related Oral Squamous Cell Carcinoma. | Cells | 2024 | 39682720 | PubTator, text mining | PubMed |
| Unveiling miRNA-Gene Regulatory Axes as Promising Biomarkers for Liver Cirrhosis and Hepatocellular Carcinoma. | ACS Omega | 2024 | 39524633 | PubTator, text mining | PubMed |
| Global Meningococcal Initiative: Insights on antibiotic resistance, control strategies and advocacy efforts in Western Europe. | J Infect | 2024 | 39489181 | PubTator, text mining | PubMed |
| Is Idiopathic Granulomatous Mastitis a Subgroup of Systemic Lupus Erythematosus? A Preliminary Study. | J Clin Med | 2024 | 39458192 | PubTator, text mining | PubMed |
| Inequalities in the risk and prevention of invasive meningococcal disease in the United States - A systematic literature review. | Hum Vaccin Immunother | 2024 | 39373020 | PubTator, text mining | PubMed |
| ENAH transcriptionally activated by YY1 promotes growth and invasion of laryngocarcinoma cells through PI3K/AKT signaling. | Eur J Pharmacol | 2024 | 39265883 | PubTator, text mining | PubMed |
| Estimating the potential number of cases prevented by infant/ toddler immunisation with a MenACWY vaccine. | Vaccine | 2024 | 39178766 | PubTator, text mining | PubMed |
| Sustainable agility of product development process based on a rough cloud technique: A case study on China's small and medium enterprises. | PLoS One | 2024 | 39173012 | PubTator, text mining | PubMed |
| Unexpected antagonism of deoxynivalenol and enniatins in intestinal toxicity through the Ras/PI3K/AKT signaling pathway. | Toxicology | 2024 | 39153657 | PubTator, text mining | PubMed |
| Insights into the Interaction Landscape of the EVH1 Domain of Mena. | Biochemistry | 2024 | 39138154 | PubTator, text mining | PubMed |
| Actin network evolution as a key driver of eukaryotic diversification. | J Cell Sci | 2024 | 39120594 | PubTator, text mining | PubMed |
| HLA-DR genotypes in patients with primary Sjögren's syndrome in Taiwan. | Kaohsiung J Med Sci | 2024 | 39115243 | PubTator, text mining | PubMed |
| PairK: Pairwise k-mer alignment for quantifying protein motif conservation in disordered regions. | bioRxiv | 2024 | 39091826 | PubTator, text mining | PubMed |
| Antiphospholipid antibodies as potential prognostic indicators of recurrent ischemic stroke. | J Stroke Cerebrovasc Dis | 2024 | 39059754 | PubTator, text mining | PubMed |
| Natural Occurrence and Co-Occurrence of Beauvericin and Enniatins in Wheat Kernels from China. | Toxins (Basel) | 2024 | 39057930 | PubTator, text mining | PubMed |
| Elaboration of the Homer1 recognition landscape reveals incomplete divergence of paralogous EVH1 domains. | Protein Sci | 2024 | 38989636 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55740/papers?page=5